Shares of the pharmacy chain plummeted 25% after The Wall Street Journal reported the CEO’s plans and the company lowered its guidance for the full year.
Trending
- Google staff call for firm to cut ties with ICE
- Trump administration launches TrumpRx website for access to discounted drugs
- Milan-Cortina 2026 Winter Olympics kicks off with multi-site, star-studded ceremony
- Saudi’s Neom replaced by Almaty as Asian Winter Games host
- FTSE 100 closes choppy week higher amid US rally
- Are we in an AI bubble?
- How Philippines’ schools embraced German language
- Menswear collections, autumn-winter 2026/27: Resisting a toxic world
